Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
1476
Apollo Commercial Real Estate
ARI
$876M
| $20.9M | ﹤0.01% |
2,132,645
+71,589
| +3% | +$607K |
|
|
EPZM
1477
DELISTED
Epizyme, Inc
EPZM
| $20.9M | ﹤0.01% |
1,301,243
+137,451
| +12% | +$2.4M |
|
1478
Twist Bioscience
TWST
$6.84B
| $20.9M | ﹤0.01% |
461,029
+56,225
| +14% | +$2.02M |
|
1479
MacroGenics
MGNX
$255M
| $20.8M | ﹤0.01% |
745,606
+2,088
| +0.3% | +$36.3K |
|
1480
Westlake Corp
WLK
$9.9B
| $20.8M | ﹤0.01% |
386,823
-11,431
| -3% | -$526K |
|
1481
Virtu Financial
VIRT
$4.91B
| $20.7M | ﹤0.01% |
878,899
+37,877
| +5% | +$885K |
|
1482
Renasant Corp
RNST
$3.96B
| $20.7M | ﹤0.01% |
832,618
-6,535
| -0.8% | -$155K |
|
1483
Coca-Cola Consolidated
COKE
$12.5B
| $20.7M | ﹤0.01% |
903,460
+12,740
| +1% | +$298K |
|
1484
Northwest Bancshares
NWBI
$2.29B
| $20.7M | ﹤0.01% |
2,024,573
+348,113
| +21% | +$3.59M |
|
1485
Resideo Technologies
REZI
$3.95B
| $20.7M | ﹤0.01% |
1,765,672
+360,063
| +26% | +$2.51M |
|
1486
AMERISAFE
AMSF
$551M
| $20.7M | ﹤0.01% |
337,946
+21,487
| +7% | +$1.34M |
|
1487
Hilltop Holdings
HTH
$2.25B
| $20.7M | ﹤0.01% |
1,120,243
+35,639
| +3% | +$612K |
|
|
CSGS
1488
DELISTED
CSG Systems International
CSGS
| $20.7M | ﹤0.01% |
499,213
+9,766
| +2% | +$447K |
|
1489
Verra Mobility
VRRM
$778M
| $20.6M | ﹤0.01% |
2,007,460
+89,747
| +5% | +$850K |
|
|
PTLA
1490
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $20.6M | ﹤0.01% |
1,144,217
+44,807
| +4% | +$623K |
|
1491
Sally Beauty Holdings
SBH
$1.51B
| $20.6M | ﹤0.01% |
1,641,020
-143,513
| -8% | -$1.57M |
|
1492
WesBanco
WSBC
$4B
| $20.5M | ﹤0.01% |
1,011,546
-5,740
| -0.6% | -$126K |
|
1493
Cytokinetics
CYTK
$11B
| $20.5M | ﹤0.01% |
871,066
+13,310
| +2% | +$250K |
|
1494
Patrick Industries
PATK
$2.87B
| $20.5M | ﹤0.01% |
501,564
-462
| -0.1% | -$14K |
|
|
KL
1495
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $20.5M | ﹤0.01% |
489,360
+14,360
| +3% | +$555K |
|
1496
APi Group
APG
$17.8B
| $20.4M | ﹤0.01% |
+2,524,665
| New | +$19.1M |
|
1497
Diamondrock Hospitality Co
DRH
$2.59B
| $20.4M | ﹤0.01% |
3,689,627
-125,892
| -3% | -$693K |
|
1498
Vicor
VICR
$10.1B
| $20.4M | ﹤0.01% |
283,298
+7,813
| +3% | +$439K |
|
1499
James River Group Holdings
JRVR
$221M
| $20.3M | ﹤0.01% |
452,180
+4,193
| +0.9% | +$156K |
|
1500
First Financial Bancorp
FFBC
$3.55B
| $20.3M | ﹤0.01% |
1,464,717
+910
| +0.1% | +$12.5K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.